At the time of writing, Braskem S.A. ADR [BAK] stock is trading at $10.81, up 1.41%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The BAK shares have gain 26.73% over the last week, with a monthly amount glided 29.62%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 19, March 2024, Braskem posts Recurring EBITDA of US$211 million in the quarter, up 13% from 3Q23. In a post published today on Yahoo Finance, BRASKEM S.A. (B3: BRKM3, BRKM5 and BRKM6; NYSE: BAK; LATIBEX: XBRK) the largest resin producer in the Americas and the world’s leading biopolymers producer, presents its 4Q23 Earnings Release.
From an analyst’s perspective:
Braskem S.A. ADR [NYSE: BAK] stock has seen the most recent analyst activity on August 29, 2023, when UBS downgraded its rating to a Sell. Previously, JP Morgan downgraded its rating to Neutral on July 05, 2023, and dropped its price target to $11. On June 14, 2023, upgrade upgraded it’s rating to Buy. UBS downgraded its rating to a Neutral. Scotiabank upgraded its rating to a Sector Outperform but $16.75 remained the price target by the analyst firm on May 08, 2023. UBS downgraded its rating to Neutral for this stock on December 15, 2022. In a note dated October 26, 2022, Scotiabank upgraded an Sector Perform rating on this stock.
For the past year, the stock price of Braskem S.A. ADR fluctuated between $6.26 and $12.67. Braskem S.A. ADR [NYSE: BAK] shares were valued at $10.81 at the most recent close of the market.
Analyzing the BAK fundamentals
According to Braskem S.A. ADR [NYSE:BAK], the company’s sales were 14.12B for trailing twelve months, which represents an -6.78% plunge. Gross Profit Margin for this corporation currently stands at 0.04% with Operating Profit Margin at -0.03%, Pretax Profit Margin comes in at -0.09%, and Net Profit Margin reading is -0.06%. To continue investigating profitability, this company’s Return on Assets is posted at -0.05, Equity is -0.76 and Total Capital is -0.03. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of14.27.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.53 points at the first support level, and at 10.26 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.03, and for the 2nd resistance point, it is at 11.26.
Braskem S.A. ADR [BAK] reported earnings per share of -$0.8 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.55/share, meaning a difference of $-0.25 and a surprise factor of -45.50%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.62 per share as compared to estimates of -$1.18 per share, a difference of $0.56 representing a surprise of 47.50%.
Ratios To Look Out For
It is important to note that Braskem S.A. ADR [NYSE:BAK] has a current ratio of 1.53. Also, the Quick Ratio is 1.02, while the Cash Ratio stands at 0.58. Considering the valuation of this stock, the price to sales ratio is 0.13, the price to book ratio is 5.24.
